Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnex MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Nexbon Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimnex MV 2mg/500mg/0.2mg Tablet

Diabex-Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Diabex-Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Maintaining regular mealtimes and carrying a fast-acting glucose source (sugary snacks or juice) is essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor might recommend blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimnex MV 2mg/500mg/0.2mg Tablet

No text provided to rephrase.

Uses of Glimnex MV 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glimnex MV 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimnex MV 2mg/500mg/0.2mg Tablet on an empty stomach.

Common Side effects of Glimnex MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimnex MV 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Glimnex MV 2mg/500mg/0.2mg Tablet on an empty stomach.

How Glimnex MV 2mg/500mg/0.2mg Tablet works:

Each Glimnex MV tablet (2mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimnex MV 2mg/500mg/0.2mg tablets with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimnex MV 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Glimnex MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Glimnex MV 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, its use is discouraged in patients experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Glimnex MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Individuals with mild to moderate liver disease should typically begin with a reduced Glimnex MV 2mg/500mg/0.2mg tablet dosage; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimnex MV 2mg/500mg/0.2mg Tablet :

Should you forget a dose of Glimnex MV 2mg/500mg/0.2mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimnex MV 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimnex MV 2mg/500mg/0.2mg Tablet

Glimnex MV 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination, used with diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Glimnex MV 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Glimnex MV 2mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Glimnex MV 2mg/500mg/0.2mg tablets with alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glimnex MV 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimnex MV 2mg/500mg/0.2m...
81
MRP 99
18% off